342 Improving TCR-T cell function against solid tumors with immune enhancing edits

• Amy Becker,
• Troy Luster,
• Ishina Balwani,
• Erica Del Aguila,
• Nishit Patel,
• Birgit Schultes,
• Justin Oh,
• Nachiket Narendra Shevale,
• Ivy Dutta,
• Nazia Ali,
• Nithila Saravanan,
• James Peter,
• Yurui Guo,
• Hanan Dahche,
• Jingyu Peng,
• Bo Han,
• Dai Liu,
• Aaron Prodeus,
• Michael Lam

Affiliations

Amy Becker

Intellia Therapeutics, Inc., Cambridge, MA, USA

Troy Luster

Intellia Therapeutics, Inc., Cambridge, MA, USA

Ishina Balwani

Intellia Therapeutics, Inc., Cambridge, MA, USA

Erica Del Aguila

Intellia Therapeutics, Inc., Cambridge, MA, USA

Nishit Patel

Intellia Therapeutics, Inc., Cambridge, MA, USA

Birgit Schultes

Intellia Therapeutics, Inc., Cambridge, MA, USA

Justin Oh

Intellia Therapeutics, Inc., Cambridge, MA, USA

Nachiket Narendra Shevale

Intellia Therapeutics, Inc., Cambridge, MA, USA

Ivy Dutta

Intellia Therapeutics, Inc., Cambridge, MA, USA

Nazia Ali

Intellia Therapeutics, Inc., Cambridge, MA, USA

Nithila Saravanan

Intellia Therapeutics, Inc., Cambridge, MA, USA

James Peter

Intellia Therapeutics, Inc., Cambridge, MA, USA

Yurui Guo

Intellia Therapeutics, Inc., Cambridge, MA, USA

Hanan Dahche

Intellia Therapeutics, Inc., Cambridge, MA, USA

Jingyu Peng

Intellia Therapeutics, Inc., Cambridge, MA, USA

Bo Han

Intellia Therapeutics, Inc., Cambridge, MA, USA

Dai Liu

Intellia Therapeutics, Inc., Cambridge, MA, USA

Aaron Prodeus

Intellia Therapeutics, Inc., Cambridge, MA, USA

Michael Lam

Intellia Therapeutics, Inc., Cambridge, MA, USA